Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Bevacizumab administration & dosage"" wg kryterium: Temat


Wyświetlanie 1-14 z 14
Tytuł :
Pilomatrix carcinoma of the lacrimal caruncle: a case report
Carcinoma pilomatricial da carúncula lacrimal: relato de caso
Autorzy :
Harbiyeli, Ibrahim Inan
Ozcan, Altan A.
Acıkalin, Arbil
Ciloglu, Emine
Shields, Carol L.
Pokaż więcej
Temat :
Hair follicle
Hair diseases
Skin neoplasms
Pilomatrixoma
Carcinoma, basal cell
Lacrimal apparatus diseases
Bevacizumab/administration & dosage
Diagnosis, Differential
Humans
Folículo piloso
Doenças do cabelo
Neoplasias cutâneas
Carcinoma basocelular
Doenças do aparelho lacrimal
Bevacizumab/administração & dosagem
Diagnóstico diferencial
Humanos
Źródło :
Arquivos Brasileiros de Oftalmologia, Volume: 83, Issue: 2, Pages: 153-156, Published: 09 MAR 2020
Opis pliku :
text/html
Tytuł :
How do we evaluate the role of focal/grid photocoagulation in the treatment of diabetic macular edema?
Autorzy :
Blindbæk, Søren Leer
Peto, Tunde
Grauslund, Jakob
Pokaż więcej
Temat :
genetic structures
Macular Edema/diagnosis
Treatment Outcome
Lasers, Semiconductor/therapeutic use
Vascular Endothelial Growth Factor A/antagonists & inhibitors
Laser Coagulation/methods
anti-VEGF
Bevacizumab/administration & dosage
Intravitreal Injections
maculopathy
photocoagulation
Angiogenesis Inhibitors/administration & dosage
diabetes
Humans
Diabetic Retinopathy/complications
Źródło :
Blindbæk, S L, Peto, T & Grauslund, J 2019, ' How do we evaluate the role of focal/grid photocoagulation in the treatment of diabetic macular ede-ma? ', Acta Ophthalmologica . https://doi.org/10.1111/aos.13997
Blindbaek, S L, Peto, T & Grauslund, J 2019, ' How do we evaluate the role of focal/grid photocoagulation in the treatment of diabetic macular edema? ', Acta Ophthalmologica, vol. 97, no. 4, pp. 339-346 . https://doi.org/10.1111/aos.13997
Opis pliku :
application/pdf
Tytuł :
Perioperative systemic therapy and cytoreductive surgery with HIPEC versus upfront cytoreductive surgery with HIPEC alone for isolated resectable colorectal peritoneal metastases : protocol of a multicentre, open-label, parralel-group, phase II-III, randomised, superiority study (CAIRO6)
Autorzy :
Rovers, Koen P
Bakkers, Checca
Simkens, Geert A A M
Burger, Jacobus W A
Nienhuijs, Simon W
Creemers, Geert-Jan M
Thijs, Anna M J
Brandt-Kerkhof, Alexandra R M
Madsen, Eva V E
Ayez, Ninos
de Boer, Nadine L
van Meerten, Esther
Tuynman, Jurriaan B
Kusters, Miranda
Sluiter, Nina R
Verheul, Henk M W
van der Vliet, Hans J
Wiezer, Marinus J
Boerma, Djamila
Wassenaar, Emma C E
Los, Maartje
Hunting, Cornelis B
Aalbers, Arend G J
Kok, Niels F M
Kuhlmann, Koert F D
Boot, Henk
Chalabi, Myriam
Kruijff, Schelto
Been, Lukas B
van Ginkel, Robert J
de Groot, Derk Jan A
Fehrmann, Rudolf S N
de Wilt, Johannes H W
Bremers, Andreas J A
de Reuver, Philip R
Radema, Sandra A
Herbschleb, Karin H
van Grevenstein, Wilhelmina M U
Witkamp, Arjen J
Koopman, Miriam
Haj Mohammad, Nadia
van Duyn, Eino B
Mastboom, Walter J B
Mekenkamp, Leonie J M
Nederend, Joost
Lahaye, Max J
Snaebjornsson, Petur
Verhoef, Cornelis
van Laarhoven, Hanneke W M
Kranenburg, Onno
Pokaż więcej
Temat :
Adjuvant chemotherapy
Colorectal Neoplasms/drug therapy
Leucovorin/administration & dosage
5-FLUOROURACIL/FOLINIC ACID
1ST-LINE TREATMENT
Oncology
Cancer Research
PLUS BEVACIZUMAB
Genetics
STAGE-II
Colorectal neoplasms
COLON-CANCER
induced
Bevacizumab
Neoplasm Metastasis
Chemotherapy, Adjuvant/adverse effects
Peritoneum/drug effects
Combined Modality Therapy
Cytoreduction surgical procedures
Randomized control trial
Female
LIVER METASTASES
Hyperthermia
Cytoreduction Surgical Procedures/adverse effects
HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY
Progression-free survival
Clinical Trial, Phase II
Middle Aged
Perioperative Period
Neoadjuvant therapy
Clinical Trial, Phase III
Randomized controlled trial
Peritoneal Neoplasms/drug therapy
NEOADJUVANT CHEMOTHERAPY
MITOMYCIN-C
Disease-Free Survival
Mortality
Fluorouracil/administration & dosage
Peritoneal neoplasms
Journal Article
Bevacizumab/administration & dosage
Oxaliplatin/administration & dosage
ADJUVANT TREATMENT
Adult
Quality of Life
Hyperthermia, induced
Humans
Male
Źródło :
BMC Cancer, 19(1). BioMed Central
Opis pliku :
image/pdf; application/pdf; text/plain
Tytuł :
A randomized phase II trial of interleukin-2 and interferon-α plus bevacizumab versus interleukin-2 and interferon-α in metastatic renal-cell carcinoma (mRCC): results from the Danish Renal Cancer Group (DaRenCa) study-1
Autorzy :
Donskov, Frede
Jensen, Niels Viggo
Smidt-Hansen, Torben
Brøndum, Line
Geertsen, Poul
Pokaż więcej
Temat :
Antineoplastic Combined Chemotherapy Protocols/therapeutic use
Kaplan-Meier Estimate
Aged
Middle Aged
Treatment Outcome
Interleukin-2/administration & dosage
Disease-Free Survival
Recombinant Proteins/administration & dosage
Kidney Neoplasms/drug therapy
Bevacizumab/administration & dosage
Adult
Female
Humans
Carcinoma, Renal Cell/drug therapy
Male
Interferon-alpha/administration & dosage
Źródło :
Donskov, F, Jensen, N V, Smidt-Hansen, T, Brøndum, L & Geertsen, P 2018, ' A randomized phase II trial of interleukin-2 and interferon-α plus bevacizumab versus interleukin-2 and interferon-α in metastatic renal-cell carcinoma (mRCC) : results from the Danish Renal Cancer Group (DaRenCa) study-1 ', Acta Oncologica, vol. 57, no. 5, pp. 589-594 . https://doi.org/10.1080/0284186X.2018.1433324
Donskov, F, Jensen, N V, Smidt-Hansen, T, Brøndum, L & Geertsen, P 2018, ' A randomized phase II trial of interleukin-2 and interferon-α plus bevacizumab versus interleukin-2 and interferon-α in metastatic renal-cell carcinoma (mRCC): results from the Danish Renal Cancer Group (DaRenCa) study-1 ', Acta Oncologica, vol. 57, no. 5, pp. 589-594 . https://doi.org/10.1080/0284186X.2018.1433324
Opis pliku :
application/pdf
Tytuł :
Which dose of bevacizumab is more effective for the treatment of aggressive posterior retinopathy of prematurity: lower or higher dose?
Qual a dose de bevacizumab no tratamento da retinopatia da prematuridade posterior agressiva: menor ou maior dose
Autorzy :
Dikci, Seyhan
Ceylan, Osman Melih
Demirel, Soner
Yılmaz, Turgut
Pokaż więcej
Temat :
Retinopathy of prematurity
Bevacizumab/administration & dosage
Light coagulation/methods
Vascular endothelial growth factor/antagonists & inhibitors
Retinopatia da prematuridade
Bevacizumab/administração & dosage
Fotocoagulação/métodos
Fator A de crescimento do endotélio vascular/antagonistas & inibidores
Źródło :
Arquivos Brasileiros de Oftalmologia, Volume: 81, Issue: 1, Pages: 12-17, Published: JAN 2018
Opis pliku :
text/html
Tytuł :
Which dose of bevacizumab is more effective for the treatment of aggressive posterior retinopathy of prematurity: lower or higher dose?
Autorzy :
Seyhan Dikci
Osman Melih Ceylan
Soner Demirel
Turgut Yılmaz
Pokaż więcej
Temat :
RE1-994
genetic structures
sense organs
Bevacizumab/administration & dosage
Retinopathy of prematurity
Bevacizumab/administração & dosage
eye diseases
Retinopatia da prematuridade
Vascular endothelial growth factor/antagonists & inhibitors
Fotocoagulação/métodos
Fator A de crescimento do endotélio vascular/antagonistas & inibidores
Ophthalmology
Light coagulation/methods
Źródło :
Arquivos Brasileiros de Oftalmologia v.81 n.1 2018
Arquivos Brasileiros de Oftalmologia
Arquivos Brasileiros de Oftalmologia, Vol 81, Iss 1, Pp 12-17
Opis pliku :
text/html
Tytuł :
Development and validation of a prognostic model for recurrent glioblastoma patients treated with bevacizumab and irinotecan
Autorzy :
Urup, Thomas
Dahlrot, Rikke Hedegaard
Grunnet, Kirsten
Christensen, Ib Jarle
Michaelsen, Signe Regner
Toft, Anders
Larsen, Vibeke Andrée
Broholm, Helle
Kosteljanetz, Michael
Hansen, Steinbjørn
Poulsen, Hans Skovgaard
Lassen, Ulrik
Pokaż więcej
Temat :
Adult
Aged
Antineoplastic Combined Chemotherapy Protocols/therapeutic use
Bevacizumab/administration & dosage
Brain Neoplasms/drug therapy
Camptothecin/administration & dosage
Cohort Studies
Disease-Free Survival
Female
Follow-Up Studies
Glioblastoma/drug therapy
Humans
Irinotecan
Male
Middle Aged
Models, Biological
Neoplasm Recurrence, Local/drug therapy
Prognosis
Retrospective Studies
Young Adult
Źródło :
Urup, T, Dahlrot, R H, Grunnet, K, Christensen, I J, Michaelsen, S R, Toft, A, Larsen, V A, Broholm, H, Kosteljanetz, M, Hansen, S, Poulsen, H S & Lassen, U 2016, ' Development and validation of a prognostic model for recurrent glioblastoma patients treated with bevacizumab and irinotecan ', Acta Oncologica, vol. 55, no. 4, pp. 418-422 . https://doi.org/10.3109/0284186X.2015.1114679
Tytuł :
Clinical aspects and perspectives of erlotinib in the treatment of patients with biliary tract cancer
Autorzy :
Jensen, Lars Henrik
Pokaż więcej
Temat :
Anticancer treatment
Biliary tract cancer
Clinical value
Erlotinib
Molecularly targeted agents
Palliative care
Bevacizumab/administration & dosage
Humans
Erlotinib Hydrochloride/administration & dosage
Molecular Targeted Therapy
Disease-Free Survival
Protein Kinase Inhibitors/administration & dosage
Animals
Biliary Tract Neoplasms/drug therapy
Drug Design
Antineoplastic Combined Chemotherapy Protocols/administration & dosage
Źródło :
Jensen, L H 2016, ' Clinical aspects and perspectives of erlotinib in the treatment of patients with biliary tract cancer ', Expert Opinion on Investigational Drugs, vol. 25, no. 3, pp. 359-365 . https://doi.org/10.1517/13543784.2016.1142973
    Wyświetlanie 1-14 z 14

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies